Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.475453782081909.
The log-likelihood improved by 3.248.
Iteration 2 of at most 500:
Optimizing with step length 0.790939102358281.
The log-likelihood improved by 3.176.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.1018.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.1436.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       1       26     1205     1052      824      341      371      381 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     280      227      139       63       46       26       10        6 
degree16 degree18 
       1        1 
1 
disease_progression 
H-positive risk:  933 897 117 837 478 122 840 403 121 60 123 69 
H-negative risk:  897 933 840 837 403 478 122 117 123 121 69 60 
New BC onsets:  1
BC status:  4999 1 
BC subtype:  4999 1 

clinical_engagement 
diagnosis 
demography 
52 new agents 
2 
disease_progression 
H-positive risk:  934 904 119 836 478 124 839 396 121 59 121 69 
H-negative risk:  904 934 839 836 396 478 124 119 121 121 69 59 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 2 1 

clinical_engagement 
diagnosis 
demography 
64 new agents 
3 
disease_progression 
H-positive risk:  940 905 120 842 474 123 839 393 121 56 119 68 
H-negative risk:  905 940 839 842 393 474 123 120 119 121 68 56 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 4 1 

clinical_engagement 
diagnosis 
demography 
50 new agents 
4 
disease_progression 
H-positive risk:  943 916 119 842 470 124 831 387 120 56 122 70 
H-negative risk:  916 943 831 842 387 470 124 119 122 120 70 56 
New BC onsets:  6
BC status:  4994 6 
BC subtype:  4994 5 1 

clinical_engagement 
diagnosis 
demography 
59 new agents 
5 
disease_progression 
H-positive risk:  954 914 120 846 457 124 833 386 120 55 122 69 
H-negative risk:  914 954 833 846 386 457 124 120 122 120 69 55 
New BC onsets:  9
BC status:  4991 9 
BC subtype:  4991 7 2 

clinical_engagement 
diagnosis 
demography 
67 new agents 
6 
disease_progression 
H-positive risk:  953 928 123 845 449 123 832 378 120 57 123 69 
H-negative risk:  928 953 832 845 378 449 123 123 123 120 69 57 
New BC onsets:  11
BC status:  4989 11 
BC subtype:  4989 7 4 

clinical_engagement 
diagnosis 
demography 
58 new agents 
7 
disease_progression 
H-positive risk:  956 927 126 850 445 122 834 373 120 54 124 69 
H-negative risk:  927 956 834 850 373 445 122 126 124 120 69 54 
New BC onsets:  12
BC status:  4988 12 
BC subtype:  4988 8 4 

clinical_engagement 
diagnosis 
demography 
66 new agents 
8 
disease_progression 
H-positive risk:  961 928 127 842 440 122 839 372 118 54 129 68 
H-negative risk:  928 961 839 842 372 440 122 127 129 118 68 54 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 9 5 

clinical_engagement 
diagnosis 
demography 
49 new agents 
9 
disease_progression 
H-positive risk:  966 927 127 845 439 123 838 369 119 53 127 67 
H-negative risk:  927 966 838 845 369 439 123 127 127 119 67 53 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 11 6 

clinical_engagement 
diagnosis 
demography 
57 new agents 
10 
disease_progression 
H-positive risk:  969 930 129 847 429 124 841 365 119 54 128 65 
H-negative risk:  930 969 841 847 365 429 124 129 128 119 65 54 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 11 6 

clinical_engagement 
diagnosis 
demography 
64 new agents 
11 
disease_progression 
H-positive risk:  973 936 128 843 431 124 843 363 118 51 127 63 
H-negative risk:  936 973 843 843 363 431 124 128 127 118 63 51 
New BC onsets:  20
BC status:  4980 20 
BC subtype:  4980 14 6 

clinical_engagement 
diagnosis 
demography 
53 new agents 
12 
disease_progression 
H-positive risk:  972 940 128 847 427 123 842 363 120 51 127 60 
H-negative risk:  940 972 842 847 363 427 123 128 127 120 60 51 
New BC onsets:  23
BC status:  4977 23 
BC subtype:  4977 16 7 

clinical_engagement 
diagnosis 
demography 
56 new agents 
13 
disease_progression 
H-positive risk:  893 871 111 920 419 110 923 367 135 51 140 60 
H-negative risk:  871 893 923 920 367 419 110 111 140 135 60 51 
New BC onsets:  27
BC status:  4973 27 
BC subtype:  4973 20 7 

clinical_engagement 
diagnosis 
demography 
184 new agents 
14 
disease_progression 
H-positive risk:  927 901 113 882 420 108 873 390 134 55 131 66 
H-negative risk:  901 927 873 882 390 420 108 113 131 134 66 55 
New BC onsets:  31
BC status:  4969 31 
BC subtype:  4969 23 8 

clinical_engagement 
diagnosis 
demography 
63 new agents 
15 
disease_progression 
H-positive risk:  936 905 114 880 416 108 872 388 132 53 132 64 
H-negative risk:  905 936 872 880 388 416 108 114 132 132 64 53 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 24 8 

clinical_engagement 
diagnosis 
demography 
64 new agents 
16 
disease_progression 
H-positive risk:  942 910 117 884 408 110 868 383 133 53 131 61 
H-negative risk:  910 942 868 884 383 408 110 117 131 133 61 53 
New BC onsets:  33
BC status:  4967 33 
BC subtype:  4967 24 9 

clinical_engagement 
diagnosis 
demography 
57 new agents 
17 
disease_progression 
H-positive risk:  945 910 118 884 406 110 867 378 136 54 131 61 
H-negative risk:  910 945 867 884 378 406 110 118 131 136 61 54 
New BC onsets:  36
BC status:  4964 36 
BC subtype:  4964 27 9 

clinical_engagement 
diagnosis 
demography 
63 new agents 
18 
disease_progression 
H-positive risk:  953 912 119 890 404 110 860 373 136 54 128 61 
H-negative risk:  912 953 860 890 373 404 110 119 128 136 61 54 
New BC onsets:  39
BC status:  4961 39 
BC subtype:  4961 29 10 

clinical_engagement 
diagnosis 
demography 
71 new agents 
19 
disease_progression 
H-positive risk:  954 924 121 891 401 109 856 368 136 51 126 63 
H-negative risk:  924 954 856 891 368 401 109 121 126 136 63 51 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 32 10 

clinical_engagement 
diagnosis 
demography 
55 new agents 
20 
disease_progression 
H-positive risk:  962 926 121 896 395 111 850 368 136 50 125 60 
H-negative risk:  926 962 850 896 368 395 111 121 125 136 60 50 
New BC onsets:  44
BC status:  4956 44 
BC subtype:  4956 34 10 

clinical_engagement 
diagnosis 
demography 
54 new agents 
21 
disease_progression 
H-positive risk:  965 927 121 898 394 112 849 364 134 49 127 60 
H-negative risk:  927 965 849 898 364 394 112 121 127 134 60 49 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 34 9 

clinical_engagement 
diagnosis 
demography 
58 new agents 
22 
disease_progression 
H-positive risk:  971 931 118 901 388 112 847 362 136 50 124 60 
H-negative risk:  931 971 847 901 362 388 112 118 124 136 60 50 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 36 9 

clinical_engagement 
diagnosis 
demography 
73 new agents 
23 
disease_progression 
H-positive risk:  985 932 119 901 384 115 840 352 138 50 125 59 
H-negative risk:  932 985 840 901 352 384 115 119 125 138 59 50 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 36 9 

clinical_engagement 
diagnosis 
demography 
61 new agents 
24 
disease_progression 
H-positive risk:  987 944 118 897 376 115 847 347 137 49 125 58 
H-negative risk:  944 987 847 897 347 376 115 118 125 137 58 49 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 36 11 

clinical_engagement 
diagnosis 
demography 
59 new agents 
25 
disease_progression 
H-positive risk:  918 876 109 964 371 110 922 343 145 47 138 57 
H-negative risk:  876 918 922 964 343 371 110 109 138 145 57 47 
New BC onsets:  50
BC status:  4950 50 
BC subtype:  4950 39 11 

clinical_engagement 
diagnosis 
demography 
193 new agents 
26 
disease_progression 
H-positive risk:  940 899 112 933 375 112 894 366 139 41 138 51 
H-negative risk:  899 940 894 933 366 375 112 112 138 139 51 41 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 44 11 

clinical_engagement 
diagnosis 
demography 
72 new agents 
27 
disease_progression 
H-positive risk:  941 907 109 927 377 113 893 367 135 41 141 49 
H-negative risk:  907 941 893 927 367 377 113 109 141 135 49 41 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 46 11 

clinical_engagement 
diagnosis 
demography 
71 new agents 
28 
disease_progression 
H-positive risk:  945 909 107 921 377 114 888 372 136 42 139 50 
H-negative risk:  909 945 888 921 372 377 114 107 139 136 50 42 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 46 11 

clinical_engagement 
diagnosis 
demography 
52 new agents 
29 
disease_progression 
H-positive risk:  948 911 108 922 370 113 892 369 137 43 137 50 
H-negative risk:  911 948 892 922 369 370 113 108 137 137 50 43 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 47 12 

clinical_engagement 
diagnosis 
demography 
65 new agents 
30 
disease_progression 
H-positive risk:  953 915 109 916 370 117 892 368 136 40 136 48 
H-negative risk:  915 953 892 916 368 370 117 109 136 136 48 40 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 49 13 

clinical_engagement 
diagnosis 
demography 
62 new agents 
31 
disease_progression 
H-positive risk:  960 920 112 913 369 115 892 363 136 39 135 46 
H-negative risk:  920 960 892 913 363 369 115 112 135 136 46 39 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 50 14 

clinical_engagement 
diagnosis 
demography 
62 new agents 
32 
disease_progression 
H-positive risk:  956 931 113 918 366 115 895 355 133 38 134 46 
H-negative risk:  931 956 895 918 355 366 115 113 134 133 46 38 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 53 13 

clinical_engagement 
diagnosis 
demography 
66 new agents 
33 
disease_progression 
H-positive risk:  956 945 113 920 362 116 890 354 131 38 129 46 
H-negative risk:  945 956 890 920 354 362 116 113 129 131 46 38 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 51 12 

clinical_engagement 
diagnosis 
demography 
74 new agents 
34 
disease_progression 
H-positive risk:  964 952 111 911 359 115 899 343 133 39 127 47 
H-negative risk:  952 964 899 911 343 359 115 111 127 133 47 39 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 52 12 

clinical_engagement 
diagnosis 
demography 
64 new agents 
35 
disease_progression 
H-positive risk:  974 947 113 914 356 115 898 335 135 42 124 47 
H-negative risk:  947 974 898 914 335 356 115 113 124 135 47 42 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 52 12 

clinical_engagement 
diagnosis 
demography 
60 new agents 
36 
disease_progression 
H-positive risk:  972 952 115 913 351 116 897 335 135 41 124 49 
H-negative risk:  952 972 897 913 335 351 116 115 124 135 49 41 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 53 13 

clinical_engagement 
diagnosis 
demography 
56 new agents 
37 
disease_progression 
H-positive risk:  887 870 107 993 349 105 985 336 145 43 133 47 
H-negative risk:  870 887 985 993 336 349 105 107 133 145 47 43 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 55 14 

clinical_engagement 
diagnosis 
demography 
143 new agents 
38 
disease_progression 
H-positive risk:  897 886 109 963 361 107 947 365 141 43 135 46 
H-negative risk:  886 897 947 963 365 361 107 109 135 141 46 43 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 55 13 

clinical_engagement 
diagnosis 
demography 
71 new agents 
39 
disease_progression 
H-positive risk:  895 886 108 964 369 107 939 370 139 43 136 44 
H-negative risk:  886 895 939 964 370 369 107 108 136 139 44 43 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 57 13 

clinical_engagement 
diagnosis 
demography 
63 new agents 
40 
disease_progression 
H-positive risk:  888 892 108 969 367 109 943 363 136 44 137 44 
H-negative risk:  892 888 943 969 363 367 109 108 137 136 44 44 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 57 13 

clinical_engagement 
diagnosis 
demography 
64 new agents 
41 
disease_progression 
H-positive risk:  889 893 109 968 363 108 951 360 136 43 137 43 
H-negative risk:  893 889 951 968 360 363 108 109 137 136 43 43 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 59 13 

clinical_engagement 
diagnosis 
demography 
63 new agents 
42 
disease_progression 
H-positive risk:  890 896 108 963 365 108 957 358 136 43 137 39 
H-negative risk:  896 890 957 963 358 365 108 108 137 136 39 43 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 59 13 

clinical_engagement 
diagnosis 
demography 
56 new agents 
43 
disease_progression 
H-positive risk:  891 889 106 969 371 110 958 350 136 43 137 40 
H-negative risk:  889 891 958 969 350 371 110 106 137 136 40 43 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 59 13 

clinical_engagement 
diagnosis 
demography 
67 new agents 
44 
disease_progression 
H-positive risk:  893 889 105 975 371 112 950 348 137 41 140 39 
H-negative risk:  889 893 950 975 348 371 112 105 140 137 39 41 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 61 13 

clinical_engagement 
diagnosis 
demography 
51 new agents 
45 
disease_progression 
H-positive risk:  896 890 107 974 371 114 943 349 136 40 141 39 
H-negative risk:  890 896 943 974 349 371 114 107 141 136 39 40 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 64 13 

clinical_engagement 
diagnosis 
demography 
58 new agents 
46 
disease_progression 
H-positive risk:  893 890 108 973 373 116 947 344 136 41 142 37 
H-negative risk:  890 893 947 973 344 373 116 108 142 136 37 41 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 64 14 

clinical_engagement 
diagnosis 
demography 
62 new agents 
47 
disease_progression 
H-positive risk:  897 895 108 961 373 113 948 344 138 44 141 38 
H-negative risk:  895 897 948 961 344 373 113 108 141 138 38 44 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 66 13 

clinical_engagement 
diagnosis 
demography 
56 new agents 
48 
disease_progression 
H-positive risk:  898 892 110 967 372 114 944 346 136 44 140 37 
H-negative risk:  892 898 944 967 346 372 114 110 140 136 37 44 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 67 13 

clinical_engagement 
diagnosis 
demography 
54 new agents 
49 
disease_progression 
H-positive risk:  842 843 100 1005 380 109 1004 342 141 45 152 37 
H-negative risk:  843 842 1004 1005 342 380 109 100 152 141 37 45 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 67 13 

clinical_engagement 
diagnosis 
demography 
157 new agents 
50 
disease_progression 
H-positive risk:  850 846 100 990 382 112 989 352 139 53 141 46 
H-negative risk:  846 850 989 990 352 382 112 100 141 139 46 53 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 67 14 

clinical_engagement 
diagnosis 
demography 
77 new agents 
51 
disease_progression 
H-positive risk:  854 856 100 988 372 114 978 359 143 52 140 44 
H-negative risk:  856 854 978 988 359 372 114 100 140 143 44 52 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 63 15 

clinical_engagement 
diagnosis 
demography 
66 new agents 
52 
disease_progression 
H-positive risk:  861 862 101 978 368 116 980 357 143 49 141 44 
H-negative risk:  862 861 980 978 357 368 116 101 141 143 44 49 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 62 15 

clinical_engagement 
diagnosis 
demography 
64 new agents 
53 
disease_progression 
H-positive risk:  856 867 101 980 366 119 978 356 143 49 139 46 
H-negative risk:  867 856 978 980 356 366 119 101 139 143 46 49 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 63 16 

clinical_engagement 
diagnosis 
demography 
59 new agents 
54 
disease_progression 
H-positive risk:  851 867 100 980 366 120 981 360 140 48 142 45 
H-negative risk:  867 851 981 980 360 366 120 100 142 140 45 48 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 60 17 

clinical_engagement 
diagnosis 
demography 
70 new agents 
55 
disease_progression 
H-positive risk:  851 871 98 983 369 121 978 354 137 48 143 47 
H-negative risk:  871 851 978 983 354 369 121 98 143 137 47 48 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 57 16 

clinical_engagement 
diagnosis 
demography 
65 new agents 
56 
disease_progression 
H-positive risk:  853 872 102 985 364 124 971 353 136 50 144 46 
H-negative risk:  872 853 971 985 353 364 124 102 144 136 46 50 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 58 15 

clinical_engagement 
diagnosis 
demography 
59 new agents 
57 
disease_progression 
H-positive risk:  853 870 103 988 366 122 970 351 137 50 142 48 
H-negative risk:  870 853 970 988 351 366 122 103 142 137 48 50 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 59 15 

clinical_engagement 
diagnosis 
demography 
78 new agents 
58 
disease_progression 
H-positive risk:  864 869 104 980 374 124 965 348 137 48 142 45 
H-negative risk:  869 864 965 980 348 374 124 104 142 137 45 48 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 60 15 

clinical_engagement 
diagnosis 
demography 
70 new agents 
59 
disease_progression 
H-positive risk:  875 874 105 984 371 119 962 345 138 46 140 41 
H-negative risk:  874 875 962 984 345 371 119 105 140 138 41 46 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 61 14 

clinical_engagement 
diagnosis 
demography 
71 new agents 
60 
disease_progression 
H-positive risk:  888 867 105 979 376 120 962 345 135 45 138 40 
H-negative risk:  867 888 962 979 345 376 120 105 138 135 40 45 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 58 14 

clinical_engagement 
diagnosis 
demography 
58 new agents 
61 
disease_progression 
H-positive risk:  822 807 101 1042 368 117 1033 346 138 46 141 39 
H-negative risk:  807 822 1033 1042 346 368 117 101 141 138 39 46 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 62 14 

clinical_engagement 
diagnosis 
demography 
106 new agents 
62 
disease_progression 
H-positive risk:  829 810 102 1014 389 122 1000 364 134 55 138 43 
H-negative risk:  810 829 1000 1014 364 389 122 102 138 134 43 55 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 65 17 

clinical_engagement 
diagnosis 
demography 
65 new agents 
63 
disease_progression 
H-positive risk:  835 817 102 1008 394 119 990 370 134 53 138 40 
H-negative risk:  817 835 990 1008 370 394 119 102 138 134 40 53 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 66 18 

clinical_engagement 
diagnosis 
demography 
60 new agents 
64 
disease_progression 
H-positive risk:  843 817 103 995 397 118 994 367 135 54 136 41 
H-negative risk:  817 843 994 995 367 397 118 103 136 135 41 54 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 66 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
65 
disease_progression 
H-positive risk:  847 811 103 995 394 118 998 365 135 54 139 41 
H-negative risk:  811 847 998 995 365 394 118 103 139 135 41 54 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 66 17 

clinical_engagement 
diagnosis 
demography 
76 new agents 
66 
disease_progression 
H-positive risk:  851 818 103 992 385 116 1000 360 138 53 141 43 
H-negative risk:  818 851 1000 992 360 385 116 103 141 138 43 53 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 65 17 

clinical_engagement 
diagnosis 
demography 
82 new agents 
67 
disease_progression 
H-positive risk:  859 819 101 996 385 114 999 350 139 52 142 44 
H-negative risk:  819 859 999 996 350 385 114 101 142 139 44 52 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 65 17 

clinical_engagement 
diagnosis 
demography 
56 new agents 
68 
disease_progression 
H-positive risk:  859 827 101 995 382 115 1001 349 136 51 138 46 
H-negative risk:  827 859 1001 995 349 382 115 101 138 136 46 51 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 65 17 

clinical_engagement 
diagnosis 
demography 
63 new agents 
69 
disease_progression 
H-positive risk:  847 833 105 998 376 114 1000 354 137 51 138 47 
H-negative risk:  833 847 1000 998 354 376 114 105 138 137 47 51 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 63 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
70 
disease_progression 
H-positive risk:  851 835 107 997 378 115 1000 349 134 47 138 49 
H-negative risk:  835 851 1000 997 349 378 115 107 138 134 49 47 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 61 18 

clinical_engagement 
diagnosis 
demography 
89 new agents 
71 
disease_progression 
H-positive risk:  847 843 110 994 371 120 999 351 133 47 137 48 
H-negative risk:  843 847 999 994 351 371 120 110 137 133 48 47 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 59 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
72 
disease_progression 
H-positive risk:  849 845 108 986 368 121 1011 349 131 47 139 46 
H-negative risk:  845 849 1011 986 349 368 121 108 139 131 46 47 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 62 21 

clinical_engagement 
diagnosis 
demography 
61 new agents 
73 
disease_progression 
H-positive risk:  796 807 102 1022 358 108 1069 354 143 48 147 46 
H-negative risk:  807 796 1069 1022 354 358 108 102 147 143 46 48 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 65 21 

clinical_engagement 
diagnosis 
demography 
118 new agents 
74 
disease_progression 
H-positive risk:  799 814 103 1017 364 108 1053 355 142 53 145 47 
H-negative risk:  814 799 1053 1017 355 364 108 103 145 142 47 53 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 65 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
75 
disease_progression 
H-positive risk:  803 820 106 1012 362 108 1047 358 141 54 143 46 
H-negative risk:  820 803 1047 1012 358 362 108 106 143 141 46 54 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 61 25 

clinical_engagement 
diagnosis 
demography 
54 new agents 
76 
disease_progression 
H-positive risk:  804 822 106 1007 359 108 1052 352 145 54 144 47 
H-negative risk:  822 804 1052 1007 352 359 108 106 144 145 47 54 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 64 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
77 
disease_progression 
H-positive risk:  810 821 110 998 364 106 1056 348 145 54 144 44 
H-negative risk:  821 810 1056 998 348 364 106 110 144 145 44 54 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 62 28 

clinical_engagement 
diagnosis 
demography 
59 new agents 
78 
disease_progression 
H-positive risk:  810 811 112 1006 370 104 1048 350 145 55 145 44 
H-negative risk:  811 810 1048 1006 350 370 104 112 145 145 44 55 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 63 28 

clinical_engagement 
diagnosis 
demography 
72 new agents 
79 
disease_progression 
H-positive risk:  812 816 111 1001 367 107 1050 348 147 54 143 44 
H-negative risk:  816 812 1050 1001 348 367 107 111 143 147 44 54 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 63 29 

clinical_engagement 
diagnosis 
demography 
79 new agents 
80 
disease_progression 
H-positive risk:  819 815 110 1006 357 106 1062 342 144 56 141 42 
H-negative risk:  815 819 1062 1006 342 357 106 110 141 144 42 56 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 63 29 

clinical_engagement 
diagnosis 
demography 
57 new agents 
81 
disease_progression 
H-positive risk:  821 811 111 1017 355 108 1059 334 144 58 140 42 
H-negative risk:  811 821 1059 1017 334 355 108 111 140 144 42 58 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 63 29 

clinical_engagement 
diagnosis 
demography 
69 new agents 
82 
disease_progression 
H-positive risk:  826 813 111 1018 357 108 1058 326 146 57 138 42 
H-negative risk:  813 826 1058 1018 326 357 108 111 138 146 42 57 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 62 30 

clinical_engagement 
diagnosis 
demography 
70 new agents 
83 
disease_progression 
H-positive risk:  824 817 110 1012 368 109 1060 317 138 61 141 43 
H-negative risk:  817 824 1060 1012 317 368 109 110 141 138 43 61 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 62 31 

clinical_engagement 
diagnosis 
demography 
58 new agents 
84 
disease_progression 
H-positive risk:  825 818 113 1008 366 107 1051 321 142 64 140 45 
H-negative risk:  818 825 1051 1008 321 366 107 113 140 142 45 64 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 62 31 

clinical_engagement 
diagnosis 
demography 
69 new agents 
85 
disease_progression 
H-positive risk:  781 772 107 1054 367 106 1096 322 146 61 144 44 
H-negative risk:  772 781 1096 1054 322 367 106 107 144 146 44 61 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 66 31 

clinical_engagement 
diagnosis 
demography 
108 new agents 
86 
disease_progression 
H-positive risk:  795 770 110 1043 374 109 1072 339 138 62 142 46 
H-negative risk:  770 795 1072 1043 339 374 109 110 142 138 46 62 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 62 31 

clinical_engagement 
diagnosis 
demography 
72 new agents 
87 
disease_progression 
H-positive risk:  796 777 109 1042 365 108 1072 343 138 63 142 45 
H-negative risk:  777 796 1072 1042 343 365 108 109 142 138 45 63 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 61 33 

clinical_engagement 
diagnosis 
demography 
67 new agents 
88 
disease_progression 
H-positive risk:  800 781 108 1046 361 107 1065 339 142 64 145 42 
H-negative risk:  781 800 1065 1046 339 361 107 108 145 142 42 64 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 59 33 

clinical_engagement 
diagnosis 
demography 
82 new agents 
89 
disease_progression 
H-positive risk:  796 784 112 1041 364 109 1059 344 137 68 143 43 
H-negative risk:  784 796 1059 1041 344 364 109 112 143 137 43 68 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 61 33 

clinical_engagement 
diagnosis 
demography 
81 new agents 
90 
disease_progression 
H-positive risk:  798 783 110 1043 358 110 1059 341 136 70 148 44 
H-negative risk:  783 798 1059 1043 341 358 110 110 148 136 44 70 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 60 33 

clinical_engagement 
diagnosis 
demography 
59 new agents 
91 
disease_progression 
H-positive risk:  799 778 109 1049 347 111 1068 339 138 67 149 46 
H-negative risk:  778 799 1068 1049 339 347 111 109 149 138 46 67 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 60 34 

clinical_engagement 
diagnosis 
demography 
78 new agents 
92 
disease_progression 
H-positive risk:  805 792 110 1038 347 110 1050 345 137 67 152 47 
H-negative risk:  792 805 1050 1038 345 347 110 110 152 137 47 67 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 61 32 

clinical_engagement 
diagnosis 
demography 
65 new agents 
93 
disease_progression 
H-positive risk:  812 793 107 1044 346 110 1041 346 137 65 154 45 
H-negative risk:  793 812 1041 1044 346 346 110 107 154 137 45 65 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 60 31 

clinical_engagement 
diagnosis 
demography 
82 new agents 
94 
disease_progression 
H-positive risk:  815 797 109 1041 337 109 1045 349 138 63 154 43 
H-negative risk:  797 815 1045 1041 349 337 109 109 154 138 43 63 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 61 31 

clinical_engagement 
diagnosis 
demography 
64 new agents 
95 
disease_progression 
H-positive risk:  819 796 111 1050 334 107 1043 346 136 63 152 43 
H-negative risk:  796 819 1043 1050 346 334 107 111 152 136 43 63 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 61 31 

clinical_engagement 
diagnosis 
demography 
58 new agents 
96 
disease_progression 
H-positive risk:  828 792 114 1060 332 108 1030 344 135 63 150 44 
H-negative risk:  792 828 1030 1060 344 332 108 114 150 135 44 63 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 61 33 

clinical_engagement 
diagnosis 
demography 
64 new agents 
97 
disease_progression 
H-positive risk:  775 740 111 1114 332 101 1072 352 143 63 157 40 
H-negative risk:  740 775 1072 1114 352 332 101 111 157 143 40 63 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 62 33 

clinical_engagement 
diagnosis 
demography 
81 new agents 
98 
disease_progression 
H-positive risk:  768 740 108 1085 356 103 1067 368 139 65 158 43 
H-negative risk:  740 768 1067 1085 368 356 103 108 158 139 43 65 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 61 33 

clinical_engagement 
diagnosis 
demography 
66 new agents 
99 
disease_progression 
H-positive risk:  764 739 109 1086 354 105 1075 368 137 63 156 44 
H-negative risk:  739 764 1075 1086 368 354 105 109 156 137 44 63 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 63 31 

clinical_engagement 
diagnosis 
demography 
75 new agents 
100 
disease_progression 
H-positive risk:  760 737 111 1094 344 104 1085 366 137 63 157 42 
H-negative risk:  737 760 1085 1094 366 344 104 111 157 137 42 63 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 61 30 

clinical_engagement 
diagnosis 
demography 
66 new agents 
101 
disease_progression 
H-positive risk:  763 736 109 1102 338 105 1085 366 136 63 156 41 
H-negative risk:  736 763 1085 1102 366 338 105 109 156 136 41 63 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 59 30 

clinical_engagement 
diagnosis 
demography 
59 new agents 
102 
disease_progression 
H-positive risk:  759 732 107 1107 339 105 1093 365 134 61 156 42 
H-negative risk:  732 759 1093 1107 365 339 105 107 156 134 42 61 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 58 29 

clinical_engagement 
diagnosis 
demography 
67 new agents 
103 
disease_progression 
H-positive risk:  755 732 106 1107 341 105 1097 361 133 61 161 41 
H-negative risk:  732 755 1097 1107 361 341 105 106 161 133 41 61 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 59 28 

clinical_engagement 
diagnosis 
demography 
77 new agents 
104 
disease_progression 
H-positive risk:  756 724 103 1109 350 104 1095 365 131 61 161 41 
H-negative risk:  724 756 1095 1109 365 350 104 103 161 131 41 61 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 60 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
105 
disease_progression 
H-positive risk:  763 733 99 1102 349 107 1098 363 130 58 157 41 
H-negative risk:  733 763 1098 1102 363 349 107 99 157 130 41 58 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 60 27 

clinical_engagement 
diagnosis 
demography 
50 new agents 
106 
disease_progression 
H-positive risk:  760 735 98 1098 356 105 1102 362 130 55 156 43 
H-negative risk:  735 760 1102 1098 362 356 105 98 156 130 43 55 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 60 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
107 
disease_progression 
H-positive risk:  760 736 98 1091 359 105 1099 367 130 53 158 44 
H-negative risk:  736 760 1099 1091 367 359 105 98 158 130 44 53 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 60 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
108 
disease_progression 
H-positive risk:  760 738 96 1094 352 108 1099 371 128 54 156 44 
H-negative risk:  738 760 1099 1094 371 352 108 96 156 128 44 54 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 61 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
109 
disease_progression 
H-positive risk:  707 694 89 1140 339 106 1158 375 131 52 162 47 
H-negative risk:  694 707 1158 1140 375 339 106 89 162 131 47 52 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 58 26 

clinical_engagement 
diagnosis 
demography 
97 new agents 
110 
disease_progression 
H-positive risk:  698 691 90 1133 348 106 1154 380 133 54 165 48 
H-negative risk:  691 698 1154 1133 380 348 106 90 165 133 48 54 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 58 32 

clinical_engagement 
diagnosis 
demography 
72 new agents 
111 
disease_progression 
H-positive risk:  703 691 90 1119 347 106 1158 384 134 55 166 47 
H-negative risk:  691 703 1158 1119 384 347 106 90 166 134 47 55 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 61 32 

clinical_engagement 
diagnosis 
demography 
59 new agents 
112 
disease_progression 
H-positive risk:  699 686 89 1125 352 105 1152 387 133 55 168 49 
H-negative risk:  686 699 1152 1125 387 352 105 89 168 133 49 55 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 61 31 

clinical_engagement 
diagnosis 
demography 
59 new agents 
113 
disease_progression 
H-positive risk:  701 683 87 1129 350 103 1158 385 134 55 166 49 
H-negative risk:  683 701 1158 1129 385 350 103 87 166 134 49 55 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 63 32 

clinical_engagement 
diagnosis 
demography 
68 new agents 
114 
disease_progression 
H-positive risk:  704 681 86 1122 352 106 1156 384 137 55 169 48 
H-negative risk:  681 704 1156 1122 384 352 106 86 169 137 48 55 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 63 32 

clinical_engagement 
diagnosis 
demography 
69 new agents 
115 
disease_progression 
H-positive risk:  705 686 87 1109 359 106 1162 377 136 56 169 48 
H-negative risk:  686 705 1162 1109 377 359 106 87 169 136 48 56 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 63 35 

clinical_engagement 
diagnosis 
demography 
59 new agents 
116 
disease_progression 
H-positive risk:  700 687 86 1110 356 108 1163 380 134 55 169 52 
H-negative risk:  687 700 1163 1110 380 356 108 86 169 134 52 55 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 64 35 

clinical_engagement 
diagnosis 
demography 
67 new agents 
117 
disease_progression 
H-positive risk:  693 683 85 1116 351 110 1161 393 132 56 170 50 
H-negative risk:  683 693 1161 1116 393 351 110 85 170 132 50 56 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 62 34 

clinical_engagement 
diagnosis 
demography 
77 new agents 
118 
disease_progression 
H-positive risk:  696 685 86 1111 349 109 1163 394 131 55 173 48 
H-negative risk:  685 696 1163 1111 394 349 109 86 173 131 48 55 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 63 33 

clinical_engagement 
diagnosis 
demography 
75 new agents 
119 
disease_progression 
H-positive risk:  695 687 86 1112 348 110 1163 389 131 55 176 48 
H-negative risk:  687 695 1163 1112 389 348 110 86 176 131 48 55 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 62 32 

clinical_engagement 
diagnosis 
demography 
73 new agents 
120 
disease_progression 
H-positive risk:  697 692 86 1109 349 110 1163 384 130 55 175 50 
H-negative risk:  692 697 1163 1109 384 349 110 86 175 130 50 55 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 63 31 

clinical_engagement 
diagnosis 
demography 
58 new agents 
121 
disease_progression 
H-positive risk:  653 656 83 1142 346 101 1208 386 140 57 176 52 
H-negative risk:  656 653 1208 1142 386 346 101 83 176 140 52 57 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 65 32 

clinical_engagement 
diagnosis 
demography 
111 new agents 
122 
disease_progression 
H-positive risk:  646 663 85 1121 354 98 1199 396 144 58 181 55 
H-negative risk:  663 646 1199 1121 396 354 98 85 181 144 55 58 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 66 29 

clinical_engagement 
diagnosis 
demography 
78 new agents 
123 
disease_progression 
H-positive risk:  647 663 87 1126 346 98 1198 397 144 58 178 58 
H-negative risk:  663 647 1198 1126 397 346 98 87 178 144 58 58 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 67 28 

clinical_engagement 
diagnosis 
demography 
77 new agents 
124 
disease_progression 
H-positive risk:  650 662 85 1124 344 99 1198 396 147 57 179 59 
H-negative risk:  662 650 1198 1124 396 344 99 85 179 147 59 57 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 67 28 

clinical_engagement 
diagnosis 
demography 
71 new agents 
125 
disease_progression 
H-positive risk:  647 663 85 1113 356 98 1202 391 149 55 184 57 
H-negative risk:  663 647 1202 1113 391 356 98 85 184 149 57 55 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 68 28 

clinical_engagement 
diagnosis 
demography 
77 new agents 
126 
disease_progression 
H-positive risk:  649 663 85 1117 355 99 1197 390 147 56 182 60 
H-negative risk:  663 649 1197 1117 390 355 99 85 182 147 60 56 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 68 29 

clinical_engagement 
diagnosis 
demography 
60 new agents 
127 
disease_progression 
H-positive risk:  644 665 85 1119 353 99 1197 393 142 58 184 61 
H-negative risk:  665 644 1197 1119 393 353 99 85 184 142 61 58 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 68 31 

clinical_engagement 
diagnosis 
demography 
60 new agents 
128 
disease_progression 
H-positive risk:  640 664 85 1116 361 99 1204 390 142 57 181 61 
H-negative risk:  664 640 1204 1116 390 361 99 85 181 142 61 57 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 69 30 

clinical_engagement 
diagnosis 
demography 
92 new agents 
129 
disease_progression 
H-positive risk:  644 675 83 1122 355 102 1197 385 142 56 180 59 
H-negative risk:  675 644 1197 1122 385 355 102 83 180 142 59 56 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 67 29 

clinical_engagement 
diagnosis 
demography 
65 new agents 
130 
disease_progression 
H-positive risk:  641 672 82 1128 350 100 1207 384 145 55 177 59 
H-negative risk:  672 641 1207 1128 384 350 100 82 177 145 59 55 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 68 28 

clinical_engagement 
diagnosis 
demography 
78 new agents 
131 
disease_progression 
H-positive risk:  635 674 86 1122 354 98 1216 378 145 56 175 61 
H-negative risk:  674 635 1216 1122 378 354 98 86 175 145 61 56 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 68 29 

clinical_engagement 
diagnosis 
demography 
67 new agents 
132 
disease_progression 
H-positive risk:  630 673 87 1128 362 95 1211 378 148 56 171 61 
H-negative risk:  673 630 1211 1128 378 362 95 87 171 148 61 56 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 66 30 

clinical_engagement 
diagnosis 
demography 
62 new agents 
133 
disease_progression 
H-positive risk:  630 678 88 1121 364 93 1208 378 154 56 170 60 
H-negative risk:  678 630 1208 1121 378 364 93 88 170 154 60 56 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 69 29 

clinical_engagement 
diagnosis 
demography 
94 new agents 
134 
disease_progression 
H-positive risk:  637 671 91 1118 368 93 1195 395 151 56 165 60 
H-negative risk:  671 637 1195 1118 395 368 93 91 165 151 60 56 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 69 31 

clinical_engagement 
diagnosis 
demography 
80 new agents 
135 
disease_progression 
H-positive risk:  648 666 93 1112 371 94 1194 393 149 55 168 57 
H-negative risk:  666 648 1194 1112 393 371 94 93 168 149 57 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
62 new agents 
136 
disease_progression 
H-positive risk:  651 666 92 1106 374 94 1197 392 148 54 168 58 
H-negative risk:  666 651 1197 1106 392 374 94 92 168 148 58 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 71 30 

clinical_engagement 
diagnosis 
demography 
76 new agents 
137 
disease_progression 
H-positive risk:  649 672 91 1104 377 94 1202 386 148 53 166 58 
H-negative risk:  672 649 1202 1104 386 377 94 91 166 148 58 53 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 70 29 

clinical_engagement 
diagnosis 
demography 
79 new agents 
138 
disease_progression 
H-positive risk:  645 673 91 1111 374 93 1203 385 148 51 168 58 
H-negative risk:  673 645 1203 1111 385 374 93 91 168 148 58 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 70 28 

clinical_engagement 
diagnosis 
demography 
80 new agents 
139 
disease_progression 
H-positive risk:  645 678 91 1119 373 93 1207 374 147 48 167 58 
H-negative risk:  678 645 1207 1119 374 373 93 91 167 147 58 48 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 71 30 

clinical_engagement 
diagnosis 
demography 
75 new agents 
140 
disease_progression 
H-positive risk:  646 683 91 1118 378 94 1205 368 150 45 167 55 
H-negative risk:  683 646 1205 1118 368 378 94 91 167 150 55 45 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 74 30 

clinical_engagement 
diagnosis 
demography 
71 new agents 
141 
disease_progression 
H-positive risk:  644 686 90 1114 376 93 1218 365 154 42 168 50 
H-negative risk:  686 644 1218 1114 365 376 93 90 168 154 50 42 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 78 30 

clinical_engagement 
diagnosis 
demography 
76 new agents 
142 
disease_progression 
H-positive risk:  637 692 88 1118 371 92 1238 356 153 40 166 49 
H-negative risk:  692 637 1238 1118 356 371 92 88 166 153 49 40 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 80 30 

clinical_engagement 
diagnosis 
demography 
81 new agents 
143 
disease_progression 
H-positive risk:  641 687 91 1125 367 89 1231 364 150 40 168 47 
H-negative risk:  687 641 1231 1125 364 367 89 91 168 150 47 40 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 78 30 

clinical_engagement 
diagnosis 
demography 
70 new agents 
144 
disease_progression 
H-positive risk:  645 689 92 1126 358 91 1229 366 147 42 169 46 
H-negative risk:  689 645 1229 1126 366 358 91 92 169 147 46 42 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 81 31 

clinical_engagement 
diagnosis 
demography 
86 new agents 
145 
disease_progression 
H-positive risk:  650 689 89 1126 357 93 1230 367 145 38 171 45 
H-negative risk:  689 650 1230 1126 367 357 93 89 171 145 45 38 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 81 30 

clinical_engagement 
diagnosis 
demography 
96 new agents 
146 
disease_progression 
H-positive risk:  655 683 90 1129 364 94 1216 370 147 36 170 46 
H-negative risk:  683 655 1216 1129 370 364 94 90 170 147 46 36 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 79 35 

clinical_engagement 
diagnosis 
demography 
68 new agents 
147 
disease_progression 
H-positive risk:  653 675 92 1135 369 92 1219 365 147 40 165 48 
H-negative risk:  675 653 1219 1135 365 369 92 92 165 147 48 40 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 79 33 

clinical_engagement 
diagnosis 
demography 
56 new agents 
148 
disease_progression 
H-positive risk:  651 669 91 1138 365 94 1223 368 149 38 165 49 
H-negative risk:  669 651 1223 1138 368 365 94 91 165 149 49 38 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 77 33 

clinical_engagement 
diagnosis 
demography 
76 new agents 
149 
disease_progression 
H-positive risk:  643 664 88 1144 369 95 1229 361 150 38 169 50 
H-negative risk:  664 643 1229 1144 361 369 95 88 169 150 50 38 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 80 32 

clinical_engagement 
diagnosis 
demography 
78 new agents 
150 
disease_progression 
H-positive risk:  644 664 87 1148 371 96 1228 359 148 39 168 48 
H-negative risk:  664 644 1228 1148 359 371 96 87 168 148 48 39 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 78 31 

clinical_engagement 
diagnosis 
demography 
98 new agents 
151 
disease_progression 
H-positive risk:  636 671 86 1149 374 96 1223 364 145 41 165 50 
H-negative risk:  671 636 1223 1149 364 374 96 86 165 145 50 41 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 76 32 

clinical_engagement 
diagnosis 
demography 
75 new agents 
152 
disease_progression 
H-positive risk:  642 672 84 1144 372 97 1228 363 141 43 166 48 
H-negative risk:  672 642 1228 1144 363 372 97 84 166 141 48 43 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 77 29 

clinical_engagement 
diagnosis 
demography 
65 new agents 
153 
disease_progression 
H-positive risk:  640 671 86 1153 376 97 1215 358 145 42 166 51 
H-negative risk:  671 640 1215 1153 358 376 97 86 166 145 51 42 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 76 31 

clinical_engagement 
diagnosis 
demography 
64 new agents 
154 
disease_progression 
H-positive risk:  643 667 87 1155 386 96 1213 347 145 43 168 50 
H-negative risk:  667 643 1213 1155 347 386 96 87 168 145 50 43 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 76 30 

clinical_engagement 
diagnosis 
demography 
76 new agents 
155 
disease_progression 
H-positive risk:  642 666 87 1150 383 95 1217 348 146 46 170 50 
H-negative risk:  666 642 1217 1150 348 383 95 87 170 146 50 46 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 78 32 

clinical_engagement 
diagnosis 
demography 
81 new agents 
156 
disease_progression 
H-positive risk:  636 676 88 1148 379 95 1218 347 150 48 164 51 
H-negative risk:  676 636 1218 1148 347 379 95 88 164 150 51 48 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 77 34 

clinical_engagement 
diagnosis 
demography 
80 new agents 
157 
disease_progression 
H-positive risk:  638 675 89 1151 379 93 1212 347 153 47 164 52 
H-negative risk:  675 638 1212 1151 347 379 93 89 164 153 52 47 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 79 33 

clinical_engagement 
diagnosis 
demography 
99 new agents 
158 
disease_progression 
H-positive risk:  643 682 89 1137 387 91 1196 360 154 45 166 50 
H-negative risk:  682 643 1196 1137 360 387 91 89 166 154 50 45 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 80 32 

clinical_engagement 
diagnosis 
demography 
80 new agents 
159 
disease_progression 
H-positive risk:  645 679 88 1141 391 92 1179 372 155 43 164 51 
H-negative risk:  679 645 1179 1141 372 391 92 88 164 155 51 43 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 79 30 

clinical_engagement 
diagnosis 
demography 
78 new agents 
160 
disease_progression 
H-positive risk:  649 680 84 1143 380 91 1187 372 154 44 166 50 
H-negative risk:  680 649 1187 1143 372 380 91 84 166 154 50 44 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 83 30 

clinical_engagement 
diagnosis 
demography 
82 new agents 
161 
disease_progression 
H-positive risk:  649 678 84 1142 375 94 1188 374 153 44 167 52 
H-negative risk:  678 649 1188 1142 374 375 94 84 167 153 52 44 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 85 29 

clinical_engagement 
diagnosis 
demography 
83 new agents 
162 
disease_progression 
H-positive risk:  651 681 87 1126 372 94 1192 381 153 43 165 55 
H-negative risk:  681 651 1192 1126 381 372 94 87 165 153 55 43 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 80 29 

clinical_engagement 
diagnosis 
demography 
67 new agents 
163 
disease_progression 
H-positive risk:  650 695 88 1123 374 95 1176 381 153 45 163 57 
H-negative risk:  695 650 1176 1123 381 374 95 88 163 153 57 45 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 84 28 

clinical_engagement 
diagnosis 
demography 
92 new agents 
164 
disease_progression 
H-positive risk:  652 697 88 1124 375 96 1176 376 155 44 159 58 
H-negative risk:  697 652 1176 1124 376 375 96 88 159 155 58 44 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 88 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
165 
disease_progression 
H-positive risk:  651 696 89 1132 374 94 1165 386 153 44 158 58 
H-negative risk:  696 651 1165 1132 386 374 94 89 158 153 58 44 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 88 27 

clinical_engagement 
diagnosis 
demography 
85 new agents 
166 
disease_progression 
H-positive risk:  657 700 89 1126 385 95 1159 379 152 45 159 54 
H-negative risk:  700 657 1159 1126 379 385 95 89 159 152 54 45 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 90 27 

clinical_engagement 
diagnosis 
demography 
70 new agents 
167 
disease_progression 
H-positive risk:  650 695 90 1134 380 99 1164 381 149 45 160 53 
H-negative risk:  695 650 1164 1134 381 380 99 90 160 149 53 45 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 90 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
168 
disease_progression 
H-positive risk:  648 696 89 1139 384 100 1162 378 149 43 158 54 
H-negative risk:  696 648 1162 1139 378 384 100 89 158 149 54 43 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
169 
disease_progression 
H-positive risk:  648 687 89 1139 388 98 1168 381 152 42 154 54 
H-negative risk:  687 648 1168 1139 381 388 98 89 154 152 54 42 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 88 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
170 
disease_progression 
H-positive risk:  646 689 88 1138 389 94 1160 391 156 41 155 53 
H-negative risk:  689 646 1160 1138 391 389 94 88 155 156 53 41 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 90 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
171 
disease_progression 
H-positive risk:  642 693 89 1135 393 94 1165 383 154 43 156 53 
H-negative risk:  693 642 1165 1135 383 393 94 89 156 154 53 43 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 93 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
172 
disease_progression 
H-positive risk:  637 691 89 1156 391 90 1158 381 154 43 158 52 
H-negative risk:  691 637 1158 1156 381 391 90 89 158 154 52 43 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 94 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
173 
disease_progression 
H-positive risk:  637 677 88 1170 395 88 1149 389 153 45 159 50 
H-negative risk:  677 637 1149 1170 389 395 88 88 159 153 50 45 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 93 24 

clinical_engagement 
diagnosis 
demography 
91 new agents 
174 
disease_progression 
H-positive risk:  636 686 87 1167 397 88 1151 385 152 46 155 50 
H-negative risk:  686 636 1151 1167 385 397 88 87 155 152 50 46 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 94 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
175 
disease_progression 
H-positive risk:  638 674 88 1174 398 88 1154 383 152 45 156 50 
H-negative risk:  674 638 1154 1174 383 398 88 88 156 152 50 45 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 91 26 

clinical_engagement 
diagnosis 
demography 
93 new agents 
176 
disease_progression 
H-positive risk:  636 675 87 1171 399 88 1162 376 153 49 154 50 
H-negative risk:  675 636 1162 1171 376 399 88 87 154 153 50 49 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
177 
disease_progression 
H-positive risk:  641 665 87 1171 397 90 1169 374 153 50 157 46 
H-negative risk:  665 641 1169 1171 374 397 90 87 157 153 46 50 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
178 
disease_progression 
H-positive risk:  640 669 85 1169 396 90 1166 376 152 51 161 45 
H-negative risk:  669 640 1166 1169 376 396 90 85 161 152 45 51 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
179 
disease_progression 
H-positive risk:  644 674 82 1165 388 91 1172 375 152 50 160 47 
H-negative risk:  674 644 1172 1165 375 388 91 82 160 152 47 50 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
180 
disease_progression 
H-positive risk:  647 671 82 1163 391 90 1167 380 153 49 157 50 
H-negative risk:  671 647 1167 1163 380 391 90 82 157 153 50 49 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
181 
disease_progression 
H-positive risk:  648 665 85 1155 389 91 1178 387 152 47 151 52 
H-negative risk:  665 648 1178 1155 387 389 91 85 151 152 52 47 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
87 new agents 
182 
disease_progression 
H-positive risk:  648 672 84 1142 392 92 1172 398 153 50 147 50 
H-negative risk:  672 648 1172 1142 398 392 92 84 147 153 50 50 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
86 new agents 
183 
disease_progression 
H-positive risk:  656 679 83 1138 390 83 1162 403 157 50 150 49 
H-negative risk:  679 656 1162 1138 403 390 83 83 150 157 49 50 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
184 
disease_progression 
H-positive risk:  658 682 84 1151 385 82 1159 389 159 49 150 52 
H-negative risk:  682 658 1159 1151 389 385 82 84 150 159 52 49 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
185 
disease_progression 
H-positive risk:  663 681 81 1151 383 83 1155 389 156 54 151 53 
H-negative risk:  681 663 1155 1151 389 383 83 81 151 156 53 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
186 
disease_progression 
H-positive risk:  670 674 81 1158 381 82 1150 388 160 51 150 55 
H-negative risk:  674 670 1150 1158 388 381 82 81 150 160 55 51 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
187 
disease_progression 
H-positive risk:  664 680 82 1160 385 80 1151 383 162 49 148 56 
H-negative risk:  680 664 1151 1160 383 385 80 82 148 162 56 49 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 85 27 

clinical_engagement 
diagnosis 
demography 
83 new agents 
188 
disease_progression 
H-positive risk:  659 684 86 1161 377 82 1155 375 165 52 148 56 
H-negative risk:  684 659 1155 1161 375 377 82 86 148 165 56 52 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
189 
disease_progression 
H-positive risk:  667 692 85 1161 383 83 1152 364 164 48 148 53 
H-negative risk:  692 667 1152 1161 364 383 83 85 148 164 53 48 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 93 26 

clinical_engagement 
diagnosis 
demography 
81 new agents 
190 
disease_progression 
H-positive risk:  668 696 84 1167 387 84 1149 352 161 50 151 51 
H-negative risk:  696 668 1149 1167 352 387 84 84 151 161 51 50 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 94 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
191 
disease_progression 
H-positive risk:  672 700 83 1164 383 83 1133 365 163 50 151 53 
H-negative risk:  700 672 1133 1164 365 383 83 83 151 163 53 50 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 91 29 

clinical_engagement 
diagnosis 
demography 
70 new agents 
192 
disease_progression 
H-positive risk:  665 702 85 1167 374 82 1133 371 163 52 154 52 
H-negative risk:  702 665 1133 1167 371 374 82 85 154 163 52 52 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 92 30 

clinical_engagement 
diagnosis 
demography 
83 new agents 
193 
disease_progression 
H-positive risk:  666 704 86 1172 370 83 1126 370 165 53 155 50 
H-negative risk:  704 666 1126 1172 370 370 83 86 155 165 50 53 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 86 30 

clinical_engagement 
diagnosis 
demography 
89 new agents 
194 
disease_progression 
H-positive risk:  660 702 83 1170 383 82 1122 374 164 52 161 47 
H-negative risk:  702 660 1122 1170 374 383 82 83 161 164 47 52 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 85 29 

clinical_engagement 
diagnosis 
demography 
78 new agents 
195 
disease_progression 
H-positive risk:  658 697 82 1167 376 83 1140 373 162 55 159 48 
H-negative risk:  697 658 1140 1167 373 376 83 82 159 162 48 55 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 80 31 

clinical_engagement 
diagnosis 
demography 
74 new agents 
196 
disease_progression 
H-positive risk:  660 705 83 1161 383 85 1135 368 163 54 155 48 
H-negative risk:  705 660 1135 1161 368 383 85 83 155 163 48 54 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 78 31 

clinical_engagement 
diagnosis 
demography 
65 new agents 
197 
disease_progression 
H-positive risk:  657 710 86 1162 382 87 1132 367 161 55 152 49 
H-negative risk:  710 657 1132 1162 367 382 87 86 152 161 49 55 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 80 31 

clinical_engagement 
diagnosis 
demography 
68 new agents 
198 
disease_progression 
H-positive risk:  652 708 85 1171 374 88 1135 368 159 56 153 51 
H-negative risk:  708 652 1135 1171 368 374 88 85 153 159 51 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 83 30 

clinical_engagement 
diagnosis 
demography 
56 new agents 
199 
disease_progression 
H-positive risk:  648 696 86 1180 384 86 1128 369 160 56 156 51 
H-negative risk:  696 648 1128 1180 369 384 86 86 156 160 51 56 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 85 30 

clinical_engagement 
diagnosis 
demography 
70 new agents 
200 
disease_progression 
H-positive risk:  646 704 88 1176 384 85 1126 371 159 54 156 51 
H-negative risk:  704 646 1126 1176 371 384 85 88 156 159 51 54 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 87 29 

clinical_engagement 
diagnosis 
demography 
73 new agents 
201 
disease_progression 
H-positive risk:  651 703 87 1164 390 86 1131 370 157 53 157 51 
H-negative risk:  703 651 1131 1164 370 390 86 87 157 157 51 53 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 88 29 

clinical_engagement 
diagnosis 
demography 
94 new agents 
202 
disease_progression 
H-positive risk:  646 701 89 1160 388 85 1138 377 156 53 156 51 
H-negative risk:  701 646 1138 1160 377 388 85 89 156 156 51 53 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 86 27 

clinical_engagement 
diagnosis 
demography 
70 new agents 
203 
disease_progression 
H-positive risk:  646 689 89 1160 402 86 1138 374 156 52 157 51 
H-negative risk:  689 646 1138 1160 374 402 86 89 157 156 51 52 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
204 
disease_progression 
H-positive risk:  644 695 90 1145 403 85 1136 381 157 51 159 54 
H-negative risk:  695 644 1136 1145 381 403 85 90 159 157 54 51 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
63 new agents 
205 
disease_progression 
H-positive risk:  648 698 90 1140 399 84 1139 380 154 53 163 52 
H-negative risk:  698 648 1139 1140 380 399 84 90 163 154 52 53 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
86 new agents 
206 
disease_progression 
H-positive risk:  662 696 87 1132 395 83 1136 384 155 53 163 54 
H-negative risk:  696 662 1136 1132 384 395 83 87 163 155 54 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
86 new agents 
207 
disease_progression 
H-positive risk:  661 698 86 1123 395 84 1134 392 154 55 164 54 
H-negative risk:  698 661 1134 1123 392 395 84 86 164 154 54 55 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
208 
disease_progression 
H-positive risk:  662 698 85 1124 391 83 1138 396 151 57 161 54 
H-negative risk:  698 662 1138 1124 396 391 83 85 161 151 54 57 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
209 
disease_progression 
H-positive risk:  664 700 84 1125 393 84 1137 390 154 54 160 55 
H-negative risk:  700 664 1137 1125 390 393 84 84 160 154 55 54 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
61 new agents 
210 
disease_progression 
H-positive risk:  663 699 81 1132 392 83 1135 392 155 51 160 57 
H-negative risk:  699 663 1135 1132 392 392 83 81 160 155 57 51 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
97 new agents 
211 
disease_progression 
H-positive risk:  666 703 84 1126 398 85 1125 390 158 52 157 56 
H-negative risk:  703 666 1125 1126 390 398 85 84 157 158 56 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
48 new agents 
212 
disease_progression 
H-positive risk:  667 704 83 1122 407 84 1112 398 155 54 158 56 
H-negative risk:  704 667 1112 1122 398 407 84 83 158 155 56 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
213 
disease_progression 
H-positive risk:  661 706 84 1110 411 86 1116 395 159 56 156 60 
H-negative risk:  706 661 1116 1110 395 411 86 84 156 159 60 56 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
214 
disease_progression 
H-positive risk:  659 704 84 1111 410 88 1125 391 157 55 154 62 
H-negative risk:  704 659 1125 1111 391 410 88 84 154 157 62 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
215 
disease_progression 
H-positive risk:  664 705 86 1118 408 86 1119 386 160 52 155 61 
H-negative risk:  705 664 1119 1118 386 408 86 86 155 160 61 52 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
216 
disease_progression 
H-positive risk:  669 710 86 1118 405 80 1114 389 159 52 156 62 
H-negative risk:  710 669 1114 1118 389 405 80 86 156 159 62 52 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
84 new agents 
217 
disease_progression 
H-positive risk:  673 707 86 1112 413 82 1102 400 158 53 151 63 
H-negative risk:  707 673 1102 1112 400 413 82 86 151 158 63 53 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
91 new agents 
218 
disease_progression 
H-positive risk:  669 709 86 1118 405 84 1112 392 159 53 151 62 
H-negative risk:  709 669 1112 1118 392 405 84 86 151 159 62 53 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
93 new agents 
219 
disease_progression 
H-positive risk:  671 704 86 1106 407 85 1125 391 155 53 153 64 
H-negative risk:  704 671 1125 1106 391 407 85 86 153 155 64 53 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
88 new agents 
220 
disease_progression 
H-positive risk:  668 705 90 1098 410 85 1128 391 156 54 154 61 
H-negative risk:  705 668 1128 1098 391 410 85 90 154 156 61 54 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
86 new agents 
221 
disease_progression 
H-positive risk:  667 706 88 1095 421 87 1124 388 157 54 150 63 
H-negative risk:  706 667 1124 1095 388 421 87 88 150 157 63 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
222 
disease_progression 
H-positive risk:  669 707 90 1090 427 87 1123 389 154 55 146 63 
H-negative risk:  707 669 1123 1090 389 427 87 90 146 154 63 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
223 
disease_progression 
H-positive risk:  670 705 88 1091 431 92 1115 396 155 52 146 59 
H-negative risk:  705 670 1115 1091 396 431 92 88 146 155 59 52 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
224 
disease_progression 
H-positive risk:  671 708 88 1091 432 93 1117 392 154 54 144 56 
H-negative risk:  708 671 1117 1091 392 432 93 88 144 154 56 54 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
225 
disease_progression 
H-positive risk:  665 711 88 1086 431 91 1125 394 155 53 146 55 
H-negative risk:  711 665 1125 1086 394 431 91 88 146 155 55 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
226 
disease_progression 
H-positive risk:  668 714 89 1086 424 92 1123 395 157 51 144 57 
H-negative risk:  714 668 1123 1086 395 424 92 89 144 157 57 51 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
59 new agents 
227 
disease_progression 
H-positive risk:  666 704 86 1104 418 93 1128 393 155 52 141 60 
H-negative risk:  704 666 1128 1104 393 418 93 86 141 155 60 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
92 new agents 
228 
disease_progression 
H-positive risk:  662 715 85 1095 427 92 1116 397 156 52 145 58 
H-negative risk:  715 662 1116 1095 397 427 92 85 145 156 58 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
229 
disease_progression 
H-positive risk:  663 711 86 1086 432 91 1098 414 158 52 149 60 
H-negative risk:  711 663 1098 1086 414 432 91 86 149 158 60 52 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
90 new agents 
230 
disease_progression 
H-positive risk:  665 719 85 1081 433 90 1094 415 158 53 147 60 
H-negative risk:  719 665 1094 1081 415 433 90 85 147 158 60 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
86 new agents 
231 
disease_progression 
H-positive risk:  671 715 86 1080 433 91 1089 417 158 54 148 58 
H-negative risk:  715 671 1089 1080 417 433 91 86 148 158 58 54 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
232 
disease_progression 
H-positive risk:  678 718 87 1085 427 94 1080 418 156 53 146 58 
H-negative risk:  718 678 1080 1085 418 427 94 87 146 156 58 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
233 
disease_progression 
H-positive risk:  686 729 87 1078 427 91 1070 419 155 54 148 56 
H-negative risk:  729 686 1070 1078 419 427 91 87 148 155 56 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 81 18 

clinical_engagement 
diagnosis 
demography 
66 new agents 
234 
disease_progression 
H-positive risk:  684 726 86 1081 428 92 1067 419 157 54 149 57 
H-negative risk:  726 684 1067 1081 419 428 92 86 149 157 57 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
65 new agents 
235 
disease_progression 
H-positive risk:  680 718 84 1088 420 93 1064 431 156 53 156 57 
H-negative risk:  718 680 1064 1088 431 420 93 84 156 156 57 53 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
236 
disease_progression 
H-positive risk:  674 719 86 1092 419 93 1068 428 156 53 155 57 
H-negative risk:  719 674 1068 1092 428 419 93 86 155 156 57 53 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
237 
disease_progression 
H-positive risk:  676 715 86 1092 419 93 1064 431 155 55 154 60 
H-negative risk:  715 676 1064 1092 431 419 93 86 154 155 60 55 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
238 
disease_progression 
H-positive risk:  671 715 85 1098 420 92 1066 434 154 53 154 58 
H-negative risk:  715 671 1066 1098 434 420 92 85 154 154 58 53 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
239 
disease_progression 
H-positive risk:  678 711 84 1083 423 91 1073 441 155 54 150 57 
H-negative risk:  711 678 1073 1083 441 423 91 84 150 155 57 54 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
240 
disease_progression 
H-positive risk:  668 714 88 1079 428 92 1082 434 154 53 150 58 
H-negative risk:  714 668 1082 1079 434 428 92 88 150 154 58 53 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
241 
disease_progression 
H-positive risk:  674 710 86 1073 444 90 1070 435 155 55 150 58 
H-negative risk:  710 674 1070 1073 435 444 90 86 150 155 58 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 72 25 

clinical_engagement 
diagnosis 
demography 
93 new agents 
242 
disease_progression 
H-positive risk:  680 712 84 1078 439 88 1071 431 152 56 149 60 
H-negative risk:  712 680 1071 1078 431 439 88 84 149 152 60 56 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
243 
disease_progression 
H-positive risk:  678 702 84 1088 438 91 1075 427 149 58 143 67 
H-negative risk:  702 678 1075 1088 427 438 91 84 143 149 67 58 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
244 
disease_progression 
H-positive risk:  676 706 84 1079 436 90 1071 435 154 59 143 67 
H-negative risk:  706 676 1071 1079 435 436 90 84 143 154 67 59 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
86 new agents 
245 
disease_progression 
H-positive risk:  675 702 85 1082 434 92 1074 434 158 58 139 67 
H-negative risk:  702 675 1074 1082 434 434 92 85 139 158 67 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
246 
disease_progression 
H-positive risk:  682 707 85 1078 437 93 1057 438 160 58 139 66 
H-negative risk:  707 682 1057 1078 438 437 93 85 139 160 66 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
247 
disease_progression 
H-positive risk:  681 708 83 1080 439 87 1056 435 163 57 142 69 
H-negative risk:  708 681 1056 1080 435 439 87 83 142 163 69 57 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
248 
disease_progression 
H-positive risk:  681 709 77 1089 438 87 1058 428 162 56 144 71 
H-negative risk:  709 681 1058 1089 428 438 87 77 144 162 71 56 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
249 
disease_progression 
H-positive risk:  691 703 78 1092 437 87 1055 427 163 51 145 71 
H-negative risk:  703 691 1055 1092 427 437 87 78 145 163 71 51 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 74 27 

clinical_engagement 
diagnosis 
demography 
85 new agents 
250 
disease_progression 
H-positive risk:  693 708 80 1087 441 88 1056 423 162 50 141 71 
H-negative risk:  708 693 1056 1087 423 441 88 80 141 162 71 50 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
82 new agents 
251 
disease_progression 
H-positive risk:  693 708 78 1093 436 85 1051 427 166 51 141 71 
H-negative risk:  708 693 1051 1093 427 436 85 78 141 166 71 51 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
67 new agents 
252 
disease_progression 
H-positive risk:  702 710 81 1089 433 87 1054 418 164 52 141 69 
H-negative risk:  710 702 1054 1089 418 433 87 81 141 164 69 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
67 new agents 
253 
disease_progression 
H-positive risk:  704 706 83 1083 439 89 1046 421 168 52 138 71 
H-negative risk:  706 704 1046 1083 421 439 89 83 138 168 71 52 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
60 new agents 
254 
disease_progression 
H-positive risk:  700 706 80 1084 439 85 1040 434 168 54 138 72 
H-negative risk:  706 700 1040 1084 434 439 85 80 138 168 72 54 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 84 27 

clinical_engagement 
diagnosis 
demography 
62 new agents 
255 
disease_progression 
H-positive risk:  702 703 80 1073 440 85 1051 436 167 55 136 72 
H-negative risk:  703 702 1051 1073 436 440 85 80 136 167 72 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
81 new agents 
256 
disease_progression 
H-positive risk:  717 693 79 1091 426 84 1048 437 164 55 133 73 
H-negative risk:  693 717 1048 1091 437 426 84 79 133 164 73 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
257 
disease_progression 
H-positive risk:  715 687 77 1098 426 82 1055 434 166 55 131 74 
H-negative risk:  687 715 1055 1098 434 426 82 77 131 166 74 55 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
258 
disease_progression 
H-positive risk:  711 686 78 1105 423 84 1057 431 166 56 132 71 
H-negative risk:  686 711 1057 1105 431 423 84 78 132 166 71 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 85 28 

clinical_engagement 
diagnosis 
demography 
68 new agents 
259 
disease_progression 
H-positive risk:  702 685 81 1104 423 83 1066 432 164 57 132 71 
H-negative risk:  685 702 1066 1104 432 423 83 81 132 164 71 57 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 88 28 

clinical_engagement 
diagnosis 
demography 
81 new agents 
260 
disease_progression 
H-positive risk:  704 686 82 1103 421 85 1067 428 161 58 134 71 
H-negative risk:  686 704 1067 1103 428 421 85 82 134 161 71 58 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
261 
disease_progression 
H-positive risk:  708 677 84 1117 416 86 1067 424 159 60 135 67 
H-negative risk:  677 708 1067 1117 424 416 86 84 135 159 67 60 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
262 
disease_progression 
H-positive risk:  704 679 85 1114 420 89 1066 424 153 65 136 65 
H-negative risk:  679 704 1066 1114 424 420 89 85 136 153 65 65 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
263 
disease_progression 
H-positive risk:  704 679 91 1109 426 89 1053 427 153 69 136 64 
H-negative risk:  679 704 1053 1109 427 426 89 91 136 153 64 69 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
90 new agents 
264 
disease_progression 
H-positive risk:  704 684 91 1088 436 92 1061 421 153 70 135 65 
H-negative risk:  684 704 1061 1088 421 436 92 91 135 153 65 70 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 91 24 

clinical_engagement 
diagnosis 
demography 
87 new agents 
265 
disease_progression 
H-positive risk:  705 692 90 1076 440 91 1060 425 154 70 133 64 
H-negative risk:  692 705 1060 1076 425 440 91 90 133 154 64 70 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 93 24 

clinical_engagement 
diagnosis 
demography 
92 new agents 
266 
disease_progression 
H-positive risk:  705 689 92 1070 442 92 1069 419 151 71 135 65 
H-negative risk:  689 705 1069 1070 419 442 92 92 135 151 65 71 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 92 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
267 
disease_progression 
H-positive risk:  702 687 94 1070 438 91 1068 420 152 75 136 67 
H-negative risk:  687 702 1068 1070 420 438 91 94 136 152 67 75 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
268 
disease_progression 
H-positive risk:  694 685 92 1069 447 90 1081 410 152 76 137 67 
H-negative risk:  685 694 1081 1069 410 447 90 92 137 152 67 76 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
269 
disease_progression 
H-positive risk:  693 680 91 1072 448 88 1084 411 151 78 136 68 
H-negative risk:  680 693 1084 1072 411 448 88 91 136 151 68 78 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
270 
disease_progression 
H-positive risk:  687 683 90 1070 454 86 1082 417 149 79 136 67 
H-negative risk:  683 687 1082 1070 417 454 86 90 136 149 67 79 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
271 
disease_progression 
H-positive risk:  685 672 89 1076 448 87 1090 419 146 82 139 67 
H-negative risk:  672 685 1090 1076 419 448 87 89 139 146 67 82 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
62 new agents 
272 
disease_progression 
H-positive risk:  693 657 90 1087 445 87 1090 417 144 83 137 70 
H-negative risk:  657 693 1090 1087 417 445 87 90 137 144 70 83 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
273 
disease_progression 
H-positive risk:  696 666 90 1078 446 86 1087 418 147 81 138 67 
H-negative risk:  666 696 1087 1078 418 446 86 90 138 147 67 81 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 93 21 

clinical_engagement 
diagnosis 
demography 
83 new agents 
274 
disease_progression 
H-positive risk:  704 664 92 1079 437 86 1092 412 146 82 140 66 
H-negative risk:  664 704 1092 1079 412 437 86 92 140 146 66 82 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
275 
disease_progression 
H-positive risk:  705 664 95 1078 432 86 1093 411 147 86 139 64 
H-negative risk:  664 705 1093 1078 411 432 86 95 139 147 64 86 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
276 
disease_progression 
H-positive risk:  699 667 97 1074 437 89 1094 404 146 89 138 66 
H-negative risk:  667 699 1094 1074 404 437 89 97 138 146 66 89 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
84 new agents 
277 
disease_progression 
H-positive risk:  706 665 99 1083 431 88 1092 403 143 88 138 64 
H-negative risk:  665 706 1092 1083 403 431 88 99 138 143 64 88 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
95 new agents 
278 
disease_progression 
H-positive risk:  698 664 99 1082 437 87 1110 389 140 88 142 64 
H-negative risk:  664 698 1110 1082 389 437 87 99 142 140 64 88 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 88 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
279 
disease_progression 
H-positive risk:  691 669 102 1075 431 85 1118 396 142 87 141 63 
H-negative risk:  669 691 1118 1075 396 431 85 102 141 142 63 87 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
280 
disease_progression 
H-positive risk:  693 670 102 1066 422 85 1122 402 145 85 142 66 
H-negative risk:  670 693 1122 1066 402 422 85 102 142 145 66 85 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
281 
disease_progression 
H-positive risk:  689 667 103 1065 422 87 1133 402 144 83 139 66 
H-negative risk:  667 689 1133 1065 402 422 87 103 139 144 66 83 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
282 
disease_progression 
H-positive risk:  694 661 104 1078 418 88 1116 409 144 82 142 64 
H-negative risk:  661 694 1116 1078 409 418 88 104 142 144 64 82 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
64 new agents 
283 
disease_progression 
H-positive risk:  696 662 103 1069 423 89 1109 416 146 81 143 63 
H-negative risk:  662 696 1109 1069 416 423 89 103 143 146 63 81 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
284 
disease_progression 
H-positive risk:  697 664 104 1067 424 87 1120 410 147 80 141 59 
H-negative risk:  664 697 1120 1067 410 424 87 104 141 147 59 80 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
285 
disease_progression 
H-positive risk:  692 675 104 1069 420 87 1110 419 146 77 142 59 
H-negative risk:  675 692 1110 1069 419 420 87 104 142 146 59 77 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
286 
disease_progression 
H-positive risk:  692 675 102 1071 425 88 1103 425 144 77 141 57 
H-negative risk:  675 692 1103 1071 425 425 88 102 141 144 57 77 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
287 
disease_progression 
H-positive risk:  692 671 101 1062 421 92 1114 424 149 76 142 56 
H-negative risk:  671 692 1114 1062 424 421 92 101 142 149 56 76 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
288 
disease_progression 
H-positive risk:  696 672 100 1061 418 95 1109 430 145 75 145 54 
H-negative risk:  672 696 1109 1061 430 418 95 100 145 145 54 75 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
289 
disease_progression 
H-positive risk:  687 672 97 1059 415 94 1116 440 143 77 148 52 
H-negative risk:  672 687 1116 1059 440 415 94 97 148 143 52 77 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
89 new agents 
290 
disease_progression 
H-positive risk:  689 677 99 1060 408 99 1125 433 139 75 146 50 
H-negative risk:  677 689 1125 1060 433 408 99 99 146 139 50 75 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
86 new agents 
291 
disease_progression 
H-positive risk:  682 673 100 1061 416 99 1128 435 138 74 146 48 
H-negative risk:  673 682 1128 1061 435 416 99 100 146 138 48 74 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 73 19 

clinical_engagement 
diagnosis 
demography 
78 new agents 
292 
disease_progression 
H-positive risk:  678 673 99 1063 420 97 1136 425 140 74 151 44 
H-negative risk:  673 678 1136 1063 425 420 97 99 151 140 44 74 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 73 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
293 
disease_progression 
H-positive risk:  682 668 99 1063 430 94 1132 421 142 74 151 44 
H-negative risk:  668 682 1132 1063 421 430 94 99 151 142 44 74 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 73 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
294 
disease_progression 
H-positive risk:  679 669 100 1065 423 90 1141 422 141 73 150 47 
H-negative risk:  669 679 1141 1065 422 423 90 100 150 141 47 73 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 75 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
295 
disease_progression 
H-positive risk:  677 677 100 1058 428 90 1141 419 141 72 149 48 
H-negative risk:  677 677 1141 1058 419 428 90 100 149 141 48 72 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 75 17 

clinical_engagement 
diagnosis 
demography 
87 new agents 
296 
disease_progression 
H-positive risk:  679 668 102 1053 428 91 1145 417 148 71 151 47 
H-negative risk:  668 679 1145 1053 417 428 91 102 151 148 47 71 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 73 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
297 
disease_progression 
H-positive risk:  677 668 101 1058 429 93 1145 417 149 68 151 44 
H-negative risk:  668 677 1145 1058 417 429 93 101 151 149 44 68 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 72 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
298 
disease_progression 
H-positive risk:  677 668 102 1060 427 94 1151 409 150 70 146 46 
H-negative risk:  668 677 1151 1060 409 427 94 102 146 150 46 70 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 72 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
299 
disease_progression 
H-positive risk:  683 663 103 1063 421 89 1158 402 158 71 145 44 
H-negative risk:  663 683 1158 1063 402 421 89 103 145 158 44 71 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 72 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
300 
disease_progression 
H-positive risk:  684 664 102 1057 417 90 1166 404 156 71 142 47 
H-negative risk:  664 684 1166 1057 404 417 90 102 142 156 47 71 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 74 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
301 
disease_progression 
H-positive risk:  687 662 102 1057 418 92 1167 408 154 66 141 46 
H-negative risk:  662 687 1167 1057 408 418 92 102 141 154 46 66 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
302 
disease_progression 
H-positive risk:  688 657 101 1059 421 92 1175 402 156 63 141 45 
H-negative risk:  657 688 1175 1059 402 421 92 101 141 156 45 63 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
64 new agents 
303 
disease_progression 
H-positive risk:  683 661 101 1052 432 94 1170 405 153 63 141 45 
H-negative risk:  661 683 1170 1052 405 432 94 101 141 153 45 63 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
304 
disease_progression 
H-positive risk:  679 662 99 1056 432 94 1168 407 149 68 145 41 
H-negative risk:  662 679 1168 1056 407 432 94 99 145 149 41 68 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 74 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
305 
disease_progression 
H-positive risk:  680 665 105 1062 427 97 1160 400 151 70 142 41 
H-negative risk:  665 680 1160 1062 400 427 97 105 142 151 41 70 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 77 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
306 
disease_progression 
H-positive risk:  679 661 105 1063 428 96 1162 399 154 69 144 40 
H-negative risk:  661 679 1162 1063 399 428 96 105 144 154 40 69 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
307 
disease_progression 
H-positive risk:  674 668 103 1060 430 99 1165 396 150 74 142 39 
H-negative risk:  668 674 1165 1060 396 430 99 103 142 150 39 74 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
308 
disease_progression 
H-positive risk:  671 671 100 1056 429 100 1161 404 148 76 146 38 
H-negative risk:  671 671 1161 1056 404 429 100 100 146 148 38 76 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
79 new agents 
309 
disease_progression 
H-positive risk:  675 671 100 1052 427 101 1161 407 146 75 145 40 
H-negative risk:  671 675 1161 1052 407 427 101 100 145 146 40 75 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 83 17 

clinical_engagement 
diagnosis 
demography 
92 new agents 
310 
disease_progression 
H-positive risk:  683 662 100 1065 419 103 1148 410 143 76 147 44 
H-negative risk:  662 683 1148 1065 410 419 103 100 147 143 44 76 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
79 new agents 
311 
disease_progression 
H-positive risk:  684 661 97 1066 417 106 1142 412 143 76 150 46 
H-negative risk:  661 684 1142 1066 412 417 106 97 150 143 46 76 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 84 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
312 
disease_progression 
H-positive risk:  691 658 95 1066 415 107 1145 407 142 78 150 46 
H-negative risk:  658 691 1145 1066 407 415 107 95 150 142 46 78 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
104 new agents 
313 
disease_progression 
H-positive risk:  696 663 96 1075 413 107 1141 399 136 80 152 42 
H-negative risk:  663 696 1141 1075 399 413 107 96 152 136 42 80 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
314 
disease_progression 
H-positive risk:  693 661 94 1089 413 106 1144 391 134 81 153 41 
H-negative risk:  661 693 1144 1089 391 413 106 94 153 134 41 81 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
315 
disease_progression 
H-positive risk:  696 667 93 1080 417 109 1129 403 133 81 150 42 
H-negative risk:  667 696 1129 1080 403 417 109 93 150 133 42 81 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
316 
disease_progression 
H-positive risk:  690 659 93 1077 417 110 1136 406 139 80 149 44 
H-negative risk:  659 690 1136 1077 406 417 110 93 149 139 44 80 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
89 new agents 
317 
disease_progression 
H-positive risk:  694 668 92 1067 415 109 1139 401 139 80 152 44 
H-negative risk:  668 694 1139 1067 401 415 109 92 152 139 44 80 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
63 new agents 
318 
disease_progression 
H-positive risk:  688 669 95 1068 415 106 1142 401 139 81 153 43 
H-negative risk:  669 688 1142 1068 401 415 106 95 153 139 43 81 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
84 new agents 
319 
disease_progression 
H-positive risk:  692 667 99 1073 403 108 1147 398 138 78 155 42 
H-negative risk:  667 692 1147 1073 398 403 108 99 155 138 42 78 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
62 new agents 
320 
disease_progression 
H-positive risk:  685 667 98 1079 399 108 1154 395 137 79 155 44 
H-negative risk:  667 685 1154 1079 395 399 108 98 155 137 44 79 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
321 
disease_progression 
H-positive risk:  683 671 97 1082 397 109 1149 396 143 79 152 42 
H-negative risk:  671 683 1149 1082 396 397 109 97 152 143 42 79 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
86 new agents 
322 
disease_progression 
H-positive risk:  681 673 97 1086 399 111 1143 395 142 77 154 42 
H-negative risk:  673 681 1143 1086 395 399 111 97 154 142 42 77 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
323 
disease_progression 
H-positive risk:  681 674 97 1078 404 111 1142 396 142 77 154 44 
H-negative risk:  674 681 1142 1078 396 404 111 97 154 142 44 77 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
324 
disease_progression 
H-positive risk:  685 672 99 1077 394 112 1138 405 146 74 151 47 
H-negative risk:  672 685 1138 1077 405 394 112 99 151 146 47 74 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
325 
disease_progression 
H-positive risk:  677 671 98 1080 397 112 1139 408 144 74 152 48 
H-negative risk:  671 677 1139 1080 408 397 112 98 152 144 48 74 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 73 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
326 
disease_progression 
H-positive risk:  680 671 97 1083 398 111 1120 422 144 74 151 49 
H-negative risk:  671 680 1120 1083 422 398 111 97 151 144 49 74 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 72 21 

clinical_engagement 
diagnosis 
demography 
85 new agents 
327 
disease_progression 
H-positive risk:  680 671 99 1088 390 112 1118 425 146 74 148 49 
H-negative risk:  671 680 1118 1088 425 390 112 99 148 146 49 74 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
328 
disease_progression 
H-positive risk:  677 661 99 1088 386 112 1121 439 148 73 146 50 
H-negative risk:  661 677 1121 1088 439 386 112 99 146 148 50 73 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 70 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
329 
disease_progression 
H-positive risk:  674 657 103 1095 381 110 1131 429 150 76 143 51 
H-negative risk:  657 674 1131 1095 429 381 110 103 143 150 51 76 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 68 21 

clinical_engagement 
diagnosis 
demography 
87 new agents 
330 
disease_progression 
H-positive risk:  677 659 101 1099 379 109 1136 427 152 70 141 50 
H-negative risk:  659 677 1136 1099 427 379 109 101 141 152 50 70 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 75 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
331 
disease_progression 
H-positive risk:  679 666 100 1090 378 109 1138 427 152 67 137 57 
H-negative risk:  666 679 1138 1090 427 378 109 100 137 152 57 67 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
332 
disease_progression 
H-positive risk:  680 655 100 1106 374 106 1145 426 149 67 136 56 
H-negative risk:  655 680 1145 1106 426 374 106 100 136 149 56 67 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
333 
disease_progression 
H-positive risk:  679 648 98 1109 386 110 1145 421 145 65 137 57 
H-negative risk:  648 679 1145 1109 421 386 110 98 137 145 57 65 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 72 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
334 
disease_progression 
H-positive risk:  684 639 97 1108 383 107 1149 420 149 68 137 59 
H-negative risk:  639 684 1149 1108 420 383 107 97 137 149 59 68 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 77 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
335 
disease_progression 
H-positive risk:  688 640 96 1101 378 110 1144 434 148 67 137 57 
H-negative risk:  640 688 1144 1101 434 378 110 96 137 148 57 67 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 79 18 

clinical_engagement 
diagnosis 
demography 
85 new agents 
336 
disease_progression 
H-positive risk:  686 648 98 1102 376 106 1142 433 151 66 135 57 
H-negative risk:  648 686 1142 1102 433 376 106 98 135 151 57 66 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 77 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
337 
disease_progression 
H-positive risk:  686 650 97 1093 380 104 1151 426 154 66 133 60 
H-negative risk:  650 686 1151 1093 426 380 104 97 133 154 60 66 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 79 18 

clinical_engagement 
diagnosis 
demography 
61 new agents 
338 
disease_progression 
H-positive risk:  678 650 98 1089 384 107 1152 433 152 64 134 59 
H-negative risk:  650 678 1152 1089 433 384 107 98 134 152 59 64 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 79 17 

clinical_engagement 
diagnosis 
demography 
73 new agents 
339 
disease_progression 
H-positive risk:  677 643 97 1096 387 105 1144 435 152 65 139 60 
H-negative risk:  643 677 1144 1096 435 387 105 97 139 152 60 65 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 81 17 

clinical_engagement 
diagnosis 
demography 
84 new agents 
340 
disease_progression 
H-positive risk:  677 645 96 1101 384 102 1135 444 157 63 136 60 
H-negative risk:  645 677 1135 1101 444 384 102 96 136 157 60 63 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 85 17 

clinical_engagement 
diagnosis 
demography 
77 new agents 
341 
disease_progression 
H-positive risk:  682 640 98 1098 388 103 1141 441 154 62 135 58 
H-negative risk:  640 682 1141 1098 441 388 103 98 135 154 58 62 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 84 16 

clinical_engagement 
diagnosis 
demography 
80 new agents 
342 
disease_progression 
H-positive risk:  677 638 101 1107 386 101 1131 444 156 61 134 64 
H-negative risk:  638 677 1131 1107 444 386 101 101 134 156 64 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
343 
disease_progression 
H-positive risk:  678 631 103 1111 387 102 1128 448 156 59 133 64 
H-negative risk:  631 678 1128 1111 448 387 102 103 133 156 64 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 88 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
344 
disease_progression 
H-positive risk:  672 635 103 1116 378 103 1130 449 156 61 130 67 
H-negative risk:  635 672 1130 1116 449 378 103 103 130 156 67 61 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 87 17 

clinical_engagement 
diagnosis 
demography 
84 new agents 
345 
disease_progression 
H-positive risk:  666 631 98 1118 390 102 1132 449 158 59 128 69 
H-negative risk:  631 666 1132 1118 449 390 102 98 128 158 69 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 89 17 

clinical_engagement 
diagnosis 
demography 
87 new agents 
346 
disease_progression 
H-positive risk:  662 633 97 1126 384 107 1130 452 156 57 127 69 
H-negative risk:  633 662 1130 1126 452 384 107 97 127 156 69 57 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 90 17 

clinical_engagement 
diagnosis 
demography 
67 new agents 
347 
disease_progression 
H-positive risk:  659 636 95 1117 381 105 1140 453 158 57 127 72 
H-negative risk:  636 659 1140 1117 453 381 105 95 127 158 72 57 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 91 17 

clinical_engagement 
diagnosis 
demography 
70 new agents 
348 
disease_progression 
H-positive risk:  659 640 93 1113 379 105 1149 446 156 58 130 72 
H-negative risk:  640 659 1149 1113 446 379 105 93 130 156 72 58 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 93 17 

clinical_engagement 
diagnosis 
demography 
71 new agents 
349 
disease_progression 
H-positive risk:  660 637 90 1110 382 103 1160 437 161 58 131 71 
H-negative risk:  637 660 1160 1110 437 382 103 90 131 161 71 58 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 92 15 

clinical_engagement 
diagnosis 
demography 
65 new agents 
350 
disease_progression 
H-positive risk:  651 636 92 1113 385 102 1169 434 158 59 128 73 
H-negative risk:  636 651 1169 1113 434 385 102 92 128 158 73 59 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 92 16 

clinical_engagement 
diagnosis 
demography 
80 new agents 
351 
disease_progression 
H-positive risk:  655 633 94 1122 382 102 1154 438 161 59 125 75 
H-negative risk:  633 655 1154 1122 438 382 102 94 125 161 75 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 90 16 

clinical_engagement 
diagnosis 
demography 
77 new agents 
352 
disease_progression 
H-positive risk:  652 639 94 1125 385 102 1148 435 158 58 125 79 
H-negative risk:  639 652 1148 1125 435 385 102 94 125 158 79 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 88 17 

clinical_engagement 
diagnosis 
demography 
74 new agents 
353 
disease_progression 
H-positive risk:  663 640 91 1124 388 101 1139 429 156 60 128 81 
H-negative risk:  640 663 1139 1124 429 388 101 91 128 156 81 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 88 17 

clinical_engagement 
diagnosis 
demography 
71 new agents 
354 
disease_progression 
H-positive risk:  665 644 92 1117 389 102 1132 434 155 61 129 80 
H-negative risk:  644 665 1132 1117 434 389 102 92 129 155 80 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 86 17 

clinical_engagement 
diagnosis 
demography 
85 new agents 
355 
disease_progression 
H-positive risk:  666 642 96 1113 384 102 1133 435 161 58 130 80 
H-negative risk:  642 666 1133 1113 435 384 102 96 130 161 80 58 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 88 16 

clinical_engagement 
diagnosis 
demography 
66 new agents 
356 
disease_progression 
H-positive risk:  671 645 96 1103 395 102 1134 432 160 56 128 78 
H-negative risk:  645 671 1134 1103 432 395 102 96 128 160 78 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 87 16 

clinical_engagement 
diagnosis 
demography 
80 new agents 
357 
disease_progression 
H-positive risk:  664 658 97 1096 394 105 1130 437 160 55 128 76 
H-negative risk:  658 664 1130 1096 437 394 105 97 128 160 76 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 88 15 

clinical_engagement 
diagnosis 
demography 
76 new agents 
358 
disease_progression 
H-positive risk:  667 665 94 1098 393 105 1131 435 159 53 123 77 
H-negative risk:  665 667 1131 1098 435 393 105 94 123 159 77 53 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 87 16 

clinical_engagement 
diagnosis 
demography 
79 new agents 
359 
disease_progression 
H-positive risk:  660 664 93 1107 395 101 1133 437 157 55 126 72 
H-negative risk:  664 660 1133 1107 437 395 101 93 126 157 72 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
89 new agents 
360 
disease_progression 
H-positive risk:  667 664 99 1105 388 98 1118 445 163 55 126 72 
H-negative risk:  664 667 1118 1105 445 388 98 99 126 163 72 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
Time difference of 15.93627 mins
This is task 30
